SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Lee who wrote (2)5/20/1996 9:17:00 PM
From: Tara Cobble   of 1154
 
Jeff, In response to your request I will try to dig up the high forecast.

I also heard a rumor that another Pharmaceutical contract with a firm may
be coming in several months. Those kind of agreements seem to drive this
stock higher. I will try to dig for more information over the next several
days.

My broker seems to be pretty high on GENE and has followed it for several
years so I trust his judgement. I have about as many shares as you at about
$10.

Look in Wednesday 5/15/96 USA Today "Money" section page 3B
Street Talk Section:
titled Short This:

The article has some comments from Money Manager Stephen Flaks, who runs the
Private Investment Fund - Flaks Fund. It was up more than 200% last year.
He was very high on Chiron last year and did extremely well. A quote from
the article "He still likes Biotech and his new favorite is Genome
Therapeutics which recently sank 30% to under $10 a share."

The article mentions 2 retail stocks that he does not find favorable and that
he is short selling.

GENE 52 week: High 15 Low 4.25 Current PE ~55

Good Luck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext